Learn More
Genscript Corporation SARS-CoV-2 Spike protein RBD
Supplier: Genscript Corporation Z037281
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases Recently the new B 1 1 529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant The B 1 1 529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern) named Omicron There are more than 30 mutations in the spike protein
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.